Labrucherie Gil M

Chief Financial Officer | SVP, COO &CFO | Director +2 more

3 companies

Excellent

Trades Analyzed

12M Win Rate

92.3%

Avg 3M Return

+31.1%

Avg 12M Return

+74.2%

Labrucherie Gil M is a SVP, COO &CFO at NEKTAR THERAPEUTICS with holdings across 3 companies. Recent SEC Form 4 filings include 6 buys and 13 sells.

Estimated insider holdings value: $26.8M based on current market prices.

Holdings by Company

NKTRMay 16, 2022

Current Shares312.9K

Value$25.67M

Net Activity-1,139,659

Bought: 0Sold: 1.14M

RZLTNov 19, 2025

Current Shares55.5K

Value$171.5K

Net Activity+52.6K

Bought: 52.6KSold: 0

SEPNFeb 27, 2025

Current Shares40.0K

Value$959.2K

Net Activity+40.0K

Bought: 40.0KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 27, 2025	SEPN Septerna, Inc.	Chief Financial Officer	Buy	10,000	$5.69	$56,866.68	+15.1%	+67.6%	+401.2%
Feb 21, 2025	SEPN Septerna, Inc.	Chief Financial Officer	Buy	30,000	$5.74	$172,296.90	+84.5%	+63.4%	+370.3%
May 16, 2022	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	17,448	$3.95	$68,919.60	-5.3%	+26.5%	-81.6%
May 4, 2022	RZLT Rezolute, Inc.	Director	Buy	52,631	$3.80	$199,997.80	New	-16.4%	-43.5%
Feb 16, 2022	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	7,579	$10.95	$82,990.05	-2.5%	-64.8%	-73.4%
Nov 18, 2021	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	24,149	$13.10	$316,390.84	-4.5%	-4.8%	-70.3%
Aug 17, 2021	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	10,867	$13.76	$149,480.61	-2.2%	-2.4%	-65.5%
May 17, 2021	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	7,898	$18.30	$144,533.40	-3.0%	-24.3%	-78.3%
Feb 16, 2021	NKTR Nektar Therapeutics	SVP, COO &CFO	Sell	7,977	$22.37	$178,445.49	-3.0%	-	-
Feb 4, 2021	NKTR Nektar Therapeutics	SVP, COO &CFO	Sale+OE	150,000	$19.86	$2,979,629.45	-10.0%	-	-